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The use of Stated Preference Discrete Choice Modelling (SPDCM) is gaining currency
in the health economics field as a method of eliciting: preferences for goods and
services; the rate at which individuals are prepared to trade off different attributes of a
good or service; and the willingness to pay for goods and services.  The purpose of this
paper is to develop welfare measures from SPDCM data that are consistent with
microeconomic welfare theory.  The theory of welfare measurement using discrete data
and links to the more well known literature using continuous data are presented.  The
estimation of welfare measures obtained from SPDCM and conjoint analysis
experiments reported in the health economics literature to date are discussed, focusing
on whether commonly adopted measures are consistent with microeconomic welfare
theory.  Finally, the Hicksian compensating variation is calculated from discrete data
collected from a SPDCM experiment designed to elicit patient preferences for
preventive asthma medications.
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1.  INTRODUCTION
The traditional approach to valuing goods and services has been to use data collected on
decisions made by individuals in the market place.  Such data are referred to as revealed
preference (RP) data.  However, RP data is often scarce and sometimes non-existent for
a number of goods and services.  Prominent examples exist in the health and
environment sectors.  In the health sector, many aspects of health care are not traded
explicitly in markets, have public good characteristics, and due to universal or private
health insurance, consumption is often free or heavily subsidised at the point of service.
Furthermore, due to the unique combination of characteristics of many health care
markets, it may not be possible to infer consumer preferences or value from the RP data
that is available
1.  Asymmetry of information between the supplier (the doctor or other
health care provider) and the consumer (the patient), lack of consumer sovereignty, and
the uncertain nature of both health and the outcomes of health care often result in the
provider acting as an imperfect agent for the patient.  This agency relationship can result
in decisions (that could be collected as RP data) that are not based on the consumer’s
preferences alone.
One technique that could be used to overcome some of the limitations involved in using
RP data to derive measures of value in the health sector is to use stated preference (SP)
data, that is, the results of what individuals say they would do rather than what they are
observed to do.  One form of SP data collection and analysis referred to as Stated
Preference Discrete Choice Modelling (SPDCM) is gaining currency within the health
economics field
2.  Rather than being limited by the availability of market data, SPDCM
involves the creation of a hypothetical market which can be constructed to suit the
relevant research question.  It can therefore be used to mimic an existing market or to
elicit preferences and values for goods or services for which a market does not exist.
The results of SPDCM experiments can be used to indirectly elicit measures of value
derived from the good or service in question in the experiment.  Such measures of value
have been calculated as the consumer’s willingness to pay (WTP) for the good or
1 The individual characteristics of many health care markets are not necessarily unique to the health care
sector.  What is unique however, is the combination and level of such characteristics occurring in a single
market.
2 Other forms of SP data include data collected via contingent valuation methods.
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service.  A small number of published studies have derived WTP measures from
SPDCM experiments.
According to microeconomic welfare theory, the value of a good or services is
calculated as the compensating variation (CV) or equivalent variation (EV).  A key
question therefore is whether the WTP measures derived from SPDCM experiments
examined in the literature to date are consistent with these exact measures of value
derived from microeconomic welfare theory.
In order to address this question, the theory underlying the compensating and equivalent
variation is reviewed.  In particular, due to the discrete nature of SPDCM experiments a
method used to derive the CV and EV from discrete data, first derived by Small and
Rosen (Small and Rosen 1981), is outlined.  The methods used in the health economics
literature to date to calculate WTP measures from SPDCM experiments are also
reviewed.  This review indicates that the latter are not directly consistent with the
former.  That is, the methods used to obtain valuations from SPDCM experiments in the
literature are not directly consistent with microeconomic welfare theory.
The methods of Small and Rosen are applied in this paper to estimate the compensating
variation from an SPDCM experiment designed to calculate preferences for preventive
asthma medication.  Despite the use of the Small and Rosen method with SPDCM data
in the environment and transport economics fields with SPDCM data, it has not been
used to calculate welfare measures using SPDCM data in the health economics arena to
date.  As such, the empirical estimation presented in this paper is the first in the health
economics field to use this method with SPDCM data.
The primary purpose of this paper is to derive welfare measures from SPDCM data that
are consistent with microeconomic welfare theory.  To do this Section 1 provides a brief
overview of SPDCM.  The well known theory of welfare measurement from continuous
data is reviewed in Section 2, in particular the derivation of compensating and
equivalent variation.  This theory is then extended to discrete data in Section 3, in
particular focusing on the method of valuing a new good or service and valuing changes
in the quality of an existing good or service.  Section 4 reviews the estimation of
welfare measures from SPDCM data in the health economics literature to date.  Such
measures are compared to the welfare theoretic measures outlined in Section 3.  Section
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5 presents an empirical estimation of an SPDCM model undertaken in a pilot study to
investigate preferences for preventive asthma medication.  The results of this model are
used to derive the compensating variation as a measure of welfare.  Section 6 presents
conclusions and suggests areas for future research.
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 2.  SPDCM
SPDCM is a method used to model consumer preferences for goods and services.
Other names given to SPDCM include discrete choice experiments (DCE), discrete
choice modelling (DCM), and discrete choice conjoint analysis.  SPDCM assumes that
individuals stated choices reflect their underlying preferences.  It allows the estimation
of the relative importance of the qualities or attributes that make up such goods and
services and the trade offs people are prepared to make between attributes, that is, their
marginal rate of substitution (MRS).  It can be used to predict the probability of
choosing a given commodity and market share and can also be used to estimate
indirectly the compensating variation for both individual attributes and the good or
service in question.  Such measures of value could potentially be used in evaluation
exercises such as cost benefit analyses and in resource allocation decisions.
SPDCM is based on both the hedonic principle (due to (Griliches 1961)) and
Lancaster’s characteristics theory of demand (Lancaster 1966): consumers have
preferences for, and derive utility from, the underlying attributes rather than the
commodity per se (Lancaster 1991).  It is assumed that consumers purchase goods and
services in order to obtain their optimal bundle of attributes and implicitly trade off
these attributes when making purchasing decisions.
The technique of SPDCM involves undertaking a controlled experiment.  A
hypothetical market is constructed by asking respondents to choose their preferred
alternative from a set of hypothetical scenarios presented in questionnaires.  Each
scenario is made up of a bundle of attributes that describe the good or service in
question with each attribute described at one of a range of levels.  For example, if the
good in question was a house, the attributes and corresponding levels could be the
number of rooms (1, 2, 3, 4), price ($250,000, $300,000, $350,000), whether it has a
garage (yes/no) etc.  The attributes remain the same in each scenario however the levels
describing the attributes vary across scenarios.  Respondents are thus asked to make
decisions about the quality (and price) differentiated versions of the same good or
service.  The choices made allow analysis of which attributes are important in the
decision at hand using random utility theory (RUT) (McFadden 1973).
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SPDCM was first applied in transport economics and subsequently in environment
economics.  It has its origins in the field of marketing, however in marketing
applications questions were generally framed as a ranking or rating exercise rather than
a discrete choice
3.  Phrasing the question in terms of a discrete choice has two key
advantages from an economic perspective.  First, responses can be analysed within the
economic framework of random utility theory (RUT) (McFadden 1973).  According to
McFadden, the Random Utility Model (RUM) is the “conceptual linkage from
preferences to choices” (McFadden 1997).  Second, it more accurately reflects how
decisions are made in the marketplace.  That is, consumers are more familiar with
choosing between a discrete number of goods and services rather than ranking or rating
them when making purchasing decisions (Ryan 1999).
Often, individuals do not explicitly know their preferences and they “usually cannot
introspect their utility functions” (Hanemann 1996).  Using SPDCM to indirectly
calculate WTP values avoids one problem associated with contingent valuation studies
whereby individuals are asked to explicitly state their WTP for health care.  Namely,
that respondents may have difficulty in explicitly stating their WTP for a good or
service as they may not be accustomed to paying for health care in the market place due
to the presence of universal or private health insurance.  In using SPDCM, the process
of having respondents make repeated choices regarding quality differentiated products
encourages them to consider the trade offs they are making across attributes and allows
them to reveal their preferences for the good or service in question and its underlying
attributes by the hypothetical choices they make.
An advantage of SPDCM when used to measure welfare is that it does so from an ex
ante perspective and as such can explicitly include any uncertainty associated with the
decision which is appropriate from a theoretical point of view (Braden and Kolstad
1991).  It also allows the valuation of non-use-demand which is particularly relevant in
such areas as the health sector and the environment where option values can be
important.
3 In a ranking exercise respondents are asked to rank the options they are presented with from best to
worst while in a rating exercise they are asked to rate an option on a scale with anchor points.
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The technique of SPDCM is not without its potential limitations.  A key consideration
in using SPDCM is the cognitive burden it places on respondents (Bennett and Blamey
2001).  Respondents are required to evaluate a number of scenarios and consider
sometimes subtle differences across these in terms of the levels of the attributes and
make tradeoffs in order to make decisions regarding the most preferred alternative in the
choice set.  The complexity of a given SPDCM experiment depends on a number of
factors including: the number of scenarios; the number of attributes; the complexity of
the levels of the attributes; the number of choice options in each scenario; and the
respondent’s familiarity with the subject area.
A related issue is that problems or inconsistencies within any of the five general steps
involved in designing and estimating an SPDCM experiment (discussed in Section 6)
will result in questionable results.  Other potential limitations include: incentive
compatibility and strategic behaviour of respondents; and framing issues or bias
4.
4 For a discussion of each of these issues see (Bennett and Blamey 2001).
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3.  REVIEW OF WELFARE MEASUREMENT FROM CONTINUOUS
DATA: COMPENSATING AND EQUIVALENT VARIATION
In economic theory individual welfare is measured by individual utility.  In order to
measure a change in an individual's welfare due to a policy change, for example, a
policy that affects prices and/or income, it would therefore make sense to measure the
resulting change in utility.  However, due to its ordinal nature, comparing utility pre and
post the policy change would only indicate the direction, but not the magnitude, of
change.  Nor would such an evaluation facilitate a comparison of the change in welfare
across individuals, which is particularly important when a policy change makes some
individuals better off and others worse off.  In order to undertake such welfare analyses
it is useful to have a monetary, and cardinal, measure of the change in welfare.
Compensating variation (CV) and equivalent variation (EV), first introduced by Hicks
(Hicks 1939)
5, offer two exact monetary measures of welfare.
The EV resulting from a proposed policy change that affects prices (or prices and
income), is the change in income at initial prices that is equivalent in its effect on utility
as the proposed price change.  The EV is an ex ante measure of the change in welfare
since it is measured before the price change, that is it uses the initial prices as the base.
EV is negative (positive) if the price change would make the consumer worse (better)
off.
In contrast, the CV is the amount of income required at the new prices to compensate
the consumer for the change in prices thereby restoring the consumer to their initial
utility level.  In this sense CV is an ex post measure of the change in welfare as it is
calculated using the new prices as the base.  CV is negative (positive) if the price
change would make the consumer worse (better) off.  For a given price change, the sign
of CV and EV will be the same (Varian 1992).
Thus, the EV is a measure of how much money needs to be given to or taken from a
consumer before the price change to make them as well off as they would be if they
faced the price change, that is at the new level of utility,  � � .  In contrast, the CV is a
5 Further developed by (Hicks 1942) and (Henderson 1941).
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measure of how much money needs to be given to or taken from the consumer after the
price change to leave them at their initial level of utility,  � � .
The derivation of the EV and CV starts from the Money Metric Indirect Utility Function
(MMIUF) (Mas-Colell, Whinston et al. 1995); (Varian 1992), the origin of which is
attributed in the literature to McKenzie (McKenzie 1957) and Samuelson (Samuelson
1974).  The MMIUF is a normalisation of an ordinal utility function and is derived from
the expenditure and indirect utility functions as follows:
� � � � � � � � � ����� � � �      (3.1)
Where �  is an arbitrary vector of reference prices,  �� � �  is the minimised expenditure
function resulting from the expenditure minimisation or “dual” problem, and  �� � �  is the
indirect utility function (IUF) derived by substituting the Marshallian demand functions
into the direct utility function in the utility maximisation or “primal” problem
6.  Thus,
the MMIUF indicates the minimum expenditure required to reach a given level of utility
� � � � � �  when prices are � .
7  Using equation 2.1, the generic change in welfare � � � �
resulting from a policy that changes prices from  � �  to  � �  can be expressed in monetary
terms as:
(3.2)
The generic  � � can be defined as the EV or CV by choosing the vector of base prices
�  to be initial prices  � �  or new prices  � �  respectively.  Letting  � � � � � � � � � �  and
� � � � � � � � � �  and noting that  � � � � � � � � � � � � � � � � � � � , the EV is given by:
� � � �
� � � � � � �
�
� � �
� � � � �
� � � �
� � � � � � ��
� �
� �
6 For a discussion of the primal and dual problems see (Mas-Colell, Whinston et al. 1995).
7 The MMIUF is simply a monotonic transformation of an indirect utility function.  Given any increasing
monotonic transformation of an indirect utility function will produce the same preference ordering, the
MMIUF is therefore itself an indirect utility function
7.  An advantage of the MMIUF is that it “involves
no introspection about unobservable” (Samuelson 1974:1263).
� � �� � � �� � � � � � � � � � � � � � � � � � � � �
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In contrast, the CV is defined as:
� � � �
� � � � � � � � � �
� � � � � �
� � � �
� � � � � � ��
� �
� �
The EV and CV can also be expressed in terms of the IUF
8:
� �




� �� � � �
� �� � � �
� �
� �
Diagrammatic representation - Indifference curves and demand curves
In the case of two goods the top half of Figure 1 depicts the CV and EV for a decrease
in the price of good 1 holding the price of good 2 (the numeraire) constant.  The




� � and is at A on indifference curve  � � .  The reduction in
� �  from 
�
� �  to
�
� � reduces the relative price of  � �  which causes the budget constraint to
swivel out.
The EV is the distance between the two indifference curves at initial prices.  The EV
indicates the increase in income required to make the consumer as well off when facing
initial prices as they would be after the price decrease, that is the consumer is at point C
where they face initial prices but are on the higher indifference curve  � � .
The CV is the distance between the two indifference curves at the new prices.  The CV
is the amount of income that would have to be taken away from the consumer at the
new prices to leave them as well off a they were before the price decrease, that is at
point B where the consumer faces the new prices but is on their initial indifference
curve � � .
8 As a note of clarification, the CV and EV outlined above have been described elsewhere  (King 1983) as
compensating and equivalent gains.  (Deaton and Meullbauer 1980) differentiate between four “consumer
surplus type measures”.  Two of which they denote as CV and EV which, in contrast to the measures
discussed above, hold utility constant and vary prices, that is movements around a single indifference
curve.  The remaining two are changes in the “money metric utility” which hold prices constant and vary
utility, that is movements between two indifference curves.  The latter two measures (CG and EG) are the
same as the CV and EV defined in the text above.  With fixed income, CG = -CV and EG = - EV.
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The EV and CV can also be represented in terms of the Hicksian, or compensated,
demand curve, as depicted in the lower half of Figure 1.  Using the fact that
� � � � � � � � � � � � � � � � � � � , the Hicksian demand curve can be recovered from the
expenditure function using Shephard’s Lemma as follows:
The EV is given by:
Which is represented by the area under the Hicksian demand curve at the new level of
utility � � � � � �� � �  between 
�
� �  and 
�
� � .  Alternatively, if 
�
� �  is higher than 
�
� � , EV
would be the negative of this area.
The representation of the CV is given by:
Which is represented by the area under the Hicksian demand curve at the initial level of
utility � � � � � �� � �  between 
�
� �  and 
�
� � .











� � � � � � � � � � � � � � � � � � �� � �
� � � � � � � � � � � � � � � � � �





�� � � � �
�
�� �
� � � � � � � � � � � �� � � � � � � � � �
� � � � � � � � � � � � � � � � � �
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Magnitudes of CV and EV
In the above diagram, the EV is larger than the CV.  The magnitudes of EV and CV for
a price change are generally not the same which is not surprising given they are valuing
the change in welfare using different prices.
9  One measures the amount of money the
consumer would accept as compensation for a price change while the other measures
the amount the consumer would be prepared to pay to avoid the same price change
(Varian 1992).  Put another way, CV and EV both measure the distance between the
two indifference curves however this distance depends on the slope of the budget
constraints at the point of measurement, that is it depends on relative prices.  The EV is
measured using initial prices while CV is measured using new prices.  As such, the
value of income depends on the availing prices since a dollar will purchase different
amounts at different relative prices.  According to Hicks, the difference depends “purely
upon income effects” (Hicks 1942).
Hicks states that the magnitude of the CV and EV are the same if “the marginal utility
of money is constant” (Hicks 1942).  More recent treatments of this issue state that the
magnitude of the CV and EV are equivalent in the restrictive case of quasilinear utility
in which case, the marginal utility of income is not only constant but is equal to one and
is independent of prices (Mas-Colell, Whinston et al. 1995), (Varian 1992).  In this case
the value of every additional dollar is independent of prices and therefore independent
of the base prices used, thus there is no difference between the resulting CV and EV
(Varian 1992).  As a result, not only will CV be equal to EV, but they will both be equal
to the Marshallian consumer surplus (CS).  The CS is the area to the left of the
Marshaillian demand and is therefore dependent on prices and income.
The relationship between EV, CV and CS
Other than in the case of quasilinear preferences, CS will be an inexact approximation
to the exact change in welfare and will lie between the CV and EV.  In particular, it can
be seen from the Slutsky equation:
9  This is in contrast to a change in income (rather than price), in which case the CV and EV will be the
same (Hanemann 1999).
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that for a normal good the derivative of the Hicksian demand curve (the term on the left
hand side in (2.10)) will be larger than the derivative of the Marshallian demand curve
(the second term on the right hand side in (2.10)) by the amount of the last term in
equation (2.10) (Varian 1992).  As such, the EV and CV will bound the CS, that is
EV>CS>CV so that the CS overstates the CV and understates the EV as is the case in
Figure 1.  The reverse holds when the good is inferior (Mas-Colell, Whinston et al.
1995).
Willig provided upper and lower bounds on the percentage errors of approximating CV
and EV with CS and suggested that if income effects are small, “the error of
approximation will be very small” (Willig 1976) P589 
10.  These bounds have since
been questioned in the literature (See (Hanemann 1982), (Bockstael, McConnell et al.
1991))
11.  Despite the fact that CS is an inexact measure of welfare in all but one
restrictive case, the conditions of which have not been borne out by the empirical data
(Slesnick 1998), it has remained popular as a method of quantifying welfare.  A
possible reason for its popularity is that it can be calculated directly from observed data
(prices and income).  The CV and EV can also be calculated from observed data but the
procedure is more complex than that required to calculate CS as is discussed below.
Preferred welfare measure
Given EV and CV will produce different magnitudes of a welfare change, a valid
question to ask is which is the more appropriate to use?  According to Wriglesworth
(Wriglesworth 1987), “the balance of opinion in the theoretical literature is in favor of
the EV as the surplus measure”
12.  One advantage EV has over CV is its ability to
simultaneously compare two policy changes.  Since EV uses the initial prices as the
base, each policy change is compared relative to the initial situation thus allowing
comparison of a number of policy options to the status quo and to each other (Varian
1992).  For example, EV allows the following type of statement to be made: “the
consumer is x times better off under policy option 1 that moves them from � � � � � �  to
� � � � � �  than policy option 2 that moves them to � � � � � � .  In contrast, CV cannot be used
to make such simultaneous comparisons since it uses the new relative prices as the base
10 (Hanemann 1991) showed that for a quality change the bound on the difference between CV and EV
depends on both income effects and substitution effects.
11 Chipman and Moore in particular have identified the limitations of CS (Chipman and Moore 1992)
12 See (Wriglesworth 1987) for more detail regarding which is the best measure in terms of satisfying
completeness, ordinality and cardinality.
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and as the new prices will differ across policies, there will be no common base to
facilitate comparison.  Another advantage of EV is that “it is easier to judge the value of
a dollar at current prices than at some hypothetical prices” (Varian 1992:162).
Measurement of CV and EV in practice
The CV and EV are not directly observable.  Measurement of CV and EV in practice
generally take one of two forms.  One approach is to recover the consumer’s IUF, and
therefore the expenditure function since the latter is the inverse of the former, from the
observable Marshallian demand functions via integration (Mas-Colell, Whinston et al.
1995).  The CV and EV can then be calculated from the expenditure function.  An
alternative method is to specify a functional form for the IUF from which the demand
functions can be derived using Roy’s identity.  Using the IUF and expenditure, the
money metric indirect utility function and therefore CV and EV can be calculated
(Varian 1992).
Relationship between EV, CV, WTP and WTA
As the majority of the studies in the health economics field that derive welfare measures
from discrete data (a review of which is the focus of Section 4) refer to such welfare
measures as willingness to pay (WTP) or, to a lesser extent, willingness to accept
(WTA), it is useful to outline the relationship between these terms.  For a reduction in
price, EV measures the minimum amount the consumer is willing to accept to forgo the
price change, while the CV measures the consumer’s WTP to secure the change.  For a
price increase, the EV measures the consumer’s WTP to avoid the change while the CV
measures the individual’s WTA compensation to tolerate the change (Hanemann 1999).
Aggregation
Aggregating welfare across individuals remains a contentious issue.  One method is to
simply sum the resulting individual changes in welfare and apply the potential Pareto
improvement criterion which is the basis of Cost Benefit Anlaysis (CBA) (Sugden and
Williams 1978).  In this case, a necessary, but not sufficient, condition for a policy to
improve welfare is that the sum of the change in welfare is greater than zero so that the
gainers could potentially compensate the losers, that is the WTP of gainers is greater
than the WTA compensation by the losers.  Two key issues have been raised in regard
to this criterion (Bockstael, McConnell et al. 1991).  First, compensation is rarely paid
and second, this criterion is biased in favour of the existing distribution of income since
14CENTRE FOR HEALTH ECONOMICS RESEARCH AND EVALUATION
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it assumes the initial distribution of income is appropriate.  The latter clearly has
distributional consequences. As such, estimates of WTP are dependent on ability to pay.
One method to account for the disparity in income and therefore ability to pay would be
to weight individual WTP to account for welfare level or position in the distribution of
welfare.
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4.  REVIEW OF WELFARE MEASUREMENT FROM DISCRETE
DATA
In many situations decisions are made between discrete or qualitative alternatives.  For
example, mode of transportation to work, choice of recreation site, or the choice of
preventive asthma medication all involve a discrete choice from a subset of alternatives.
In such situations the theory outlined in Section 3 for continuous data needs to be
modified in order to estimate the changes in welfare induced from changes in either the
price or quality of such goods and services.  This is because the discreteness of the
choices means that demand functions cannot be integrated over or alternatively indirect
utility and expenditure functions cannot be differentiated (Small and Rosen 1981).  As
such, the conventional theory of welfare measurement must be modified to take account
of discrete data.  Small and Rosen completed this task in their seminal 1981 paper in
which they present the theory behind the derivation of compensating variation from
discrete data for both a price and quality change.  The latter is discussed here
13.
Hanemann (Hanemann 1982) is also attributed in the literature with the development of
methods to evaluate CV from discrete data in the field of contingent variation.
The evaluation of quality changes is of interest for many discrete choice problems.  For
example, a change in: the duration of a bus trip; quality of the water at a recreation site;
or the required frequency of taking asthma medication could potentially result in
changes in welfare for the individuals considering the choice of mode of transport,
recreation site or asthma medication, respectively.
Derivation of CV for a quality change
The following derivation of the CV for a quality change follows that of Small and
Rosen (Small and Rosen 1981).  Consider the case in which there are three commodities
that are available in continuous quantities, � � , � �   and  � �  where  � �  is the numeraire
good.  Goods  � �  and  � �  are mutually exclusive, hence:
� � � � � � (4.1)
13 See Small and Rosen (1981) for the derivation of the CV for a price change using discrete data.
Alternatively, price can be treated as an attribute of the good or service and the CV resulting from a price
change can be calculated in the same way as for a quality change.
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which prevents both  � �  and  � �  being consumed in positive amounts.  The discrete
choice is therefore between  � �  and  � � .  One of the commodities, say good 1, has a
quality variable associated with it.  The twice differentiable, strictly quasi-concave
utility function is:
� � � � � � � � � � � � � � � � (4.2)
where the scalar  � �  describes the quality variable which is assumed to be exogenous to
consumers.  Utility is assumed to be finite whenever either  � �  or � �  are zero.  It is also










� � � � � (4.3)
Consumers maximise 4.2 subject to the budget constraint and non negativity constraint:
� � � � � �� � � � � � � � (4.4)
� � � � � � ����� � � � � � � (4.5)
An interior solution is ensured by assuming that the numeraire and either  � �  or  � �  are
consumed in positive amounts.
Let � � � � � � � � � � � � �
�
� � �  be the value of the IUF at initial prices and income,
� � � � � � � � � � � � �
�
� � �  be the IUF at final prices, and  � � � � � � � � � � �  be the minimum
expenditure required to achieve utility � .  The IUF and expenditure function satisfy:
� � � � � � � � � � � � � � � � � � � � � � � � � � � (4.6)
Taking the quality derivative of equation (4.6) produces:
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Where �  denotes the marginal utility of income which is equal to � � � � � .  The
marginal utility of income is used in equation (4.8) to convert the marginal utility of
quality into monetary units.  Constant marginal utility of income is often a helpful, but
not a necessary, condition for equation (4.8) to hold.
The change in the area under the compensated demand curve after it has shifted in
response to a change in quality is presented in Small and Rosen’s Theorem 2 as







� � � � � � �� � � � � �
�










For a change in quality from  � �  to  � � , integrating over 4.9 produces the CV
� � � � � � � �
�
� � � � �
�
� � � �
�
�
� � � � � � �� � � � � � � � � � � �
��
�
� � � � (4.10)
While this is a useful result if data are available to estimate the compensated demand
curve which can be integrated over, stated preference models do not usually generate
demand curves.  Fortunately, the CV can be derived directly from the expenditure
function and from random utility models which do not depend on demand functions
(Bockstael et al 1991).
Application to Random Utility Theory
Given the inherent uncertainty regarding which alternative will be chosen in SPDCM
experiments, such models are estimated using random utility theory (RUT) and
econometric models.  As the ultimate aim of this paper is to derive welfare measures
from SPDCM experiments, it is necessary to investigate how the CV formula outlined
above is calculated from stochastic utility models.
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RUT is based on the premise that although the individual knows their own preferences
with certainty, some components of their preferences are unobservable to the researcher,
and therefore treated as random (McFadden 1973).  The IUF, for individual �
conditional on choice of good � , �� � , is assumed to be additively separable into 2
components:
� � � � �� � � � � �� � � � �� � � � � � � � � � � � � � � � � � (4.11)
The first term,  � � , is the deterministic or non stochastic component, the form of which
is assumed to be the same for all individuals in the population.  This term is a function
of price, quality attributes, income and the vector � � , which contains observable
characteristics of the individual.  The final term is the realisation for individual � of the
unexplainable or stochastic component and is assumed to be independent of the
components of �� � .
The systematic part of the IUF can be described as follows:
� �� �� � � � � � � � � � (4.12)
where �� �  is the vector of attributes, including price and quality, of the ��� good as
viewed by the ��� individual and  � �  is a vector of personal characteristics for individual
� including income.
The IUF represents the maximum attainable utility for given prices and income.  There
are four properties of an IUF.  First, it must be homogeneous of degree zero in prices
and income.  This means that multiplying both prices and income by a positive constant
will have no effect on the IUF.  Second, the IUF must be non increasing in prices.  This
implies that as price rises utility must not increase.  Third it must be quasiconvex and
finally it must be continuous.  The first two imply constraints on the IUF which is
estimated in SPDCM experiments.  One way to impose the property of homogeneity of
degree zero is to enter price and income as a ratio in the model to be estimated.  The
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implication of the second property that the IUF be non increasing in price is that the
coefficient on the price attribute in the random utility model should be non positive.
In the RUT framework an individual chooses the alternative from the choice set that
results in the highest utility (McFadden 1973).  Thus, selection of one alternative
implies that the utility derived from that alternative is greater than the utility associated
with all other options in the choice set.
Due to the fact that overall utility is random, only the probability of choice of one
option over another can be analysed (Adamowicz, Boxall et al. 1999).  Individual � will
choose good 1 if and only if the utility derived from good 1 is greater than the utility
derived any other good in the choice set� . Assuming a joint probability distribution
for � � , the probability that utility is maximised by choosing good 1 is given by:
� �
� �
� � � � �� � � � � �
� �
� �
� � � � � �
� � � �
� �
� � � ��
� � ��
� � ��
� �� �� �





Where � � � is conditioned on � , �and� .  It is the prediction of the fraction of
individuals who choose good 1.  Thus, the probability that good 1 will be chosen
depends on whether the utility derived from option 1 is greater than the utility derived
from all other options.
Assuming a Type 1 extreme value error distribution with scale parameter �  produces





















where the scale parameter�  is usually set equal to one (Adamowicz, Louviere et al.
1994).  The scale parameter cannot be identified in a single sample but can be identified
if two separate samples are analysed together.  The relative scale parameter accounts for
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the difference in the variation of the unobserved effects (Adamowicz et al 1994, Swait
and Louviere 1993).






















The CV is given by:





� � � � �
� �
� �� � � �� �
�
(4.16)
Given the logit specification of the choice probability, the integral in equation (4.16)





























has been referred to in the environmental and transport literature as the inclusive value
(Bockstael, McConnell et al. 1991) and (Ben - Akiva and Lerman 1985). Ben - Akiva
and Lerman define the inclusive value as “the expected maximum utility of a subset of
alternatives” (Ben - Akiva and Lerman 1985: 282).  The inclusive value weights the
IUFs associated with each alternative by the probability of choosing each alternative
(Bockstael, McConnell et al. 1991).  As such, the CV formula is related to the
probability of choosing a given alternative: a low probability of choosing a given option
results in a low CV while a high probability of choosing a given option results in a high
CV (Bockstael, McConnell et al. 1991).  This relationship between the CV and the
probability of choosing each alternative is not surprising given the derivative of the
term in the square brackets in (4.17) with respect to V is equation (4.16).  In order to
14 Alternatively a probit model could be estimated by assuming a standard normal error distribution rather
than a logistic distribution.  For the derivation of the CV formula for a probit model see Small and Rosen
(1981).
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express the change in utility in monetary terms, the difference in the inclusive values in
equation (4.17) is scaled by � , the marginal utility of income (Trajtenberg 1989).  The
marginal utility of income is given by the coefficient on income in the estimated IUF.
However, often information on income is not available.  This has been addressed in a
number of empirical applications by interpreting the coefficient on the price attribute
(which represents the marginal disutility of price) as the negative of the marginal utility
of income (Louviere, Hensher et al. 2000).  In this case the CV formula is represented
by:






    (4.18)
where � �  is the coefficient on the price variable.
Although equation (4.17) is referred to as the CV, it is in fact equivalent to the EV and
Marshallian CS if the marginal utility of income (represented by � ) is assumed to be
constant and equal to one (see Section 3).
In practice, equation (4.17) can be used to derive welfare measures arising from a
change in a single quality attribute in a single good or a change in all quality attributes
associated with a good.  It can also be used to value the benefits associated with the
introduction of a new good or service if its characteristics can be described (Bockstael,
























where � � � �  is the systematic component of the IUF of the new good or service.



















    (4.20)
(Bockstael, McConnell et al. 1991)
22CENTRE FOR HEALTH ECONOMICS RESEARCH AND EVALUATION
Lancsar
CHERE Discussion Paper 48 – August 2002 23
Rate of change in the CV as quality improves
Since the unobserved factors are additive in equation (4.11), the rate of change in the
CV for an infinitesimal change in quality can be calculated (McFadden 1999).  For
example, if quality improves infinitesimally from  � �  to  � � � � � � � � � �  which results in
an infinitesimal change in the choice probabilities  � � � � � � � � �� � �  then the
compensating income reduction for a fixed alternative  �  is given by:





















� �        (4.19)
where � � � � � is infinitesimal and can therefore be ignored for practical purposes.  The
use of this formula is appropriate if the choice option of interest is chosen with certainty
or if the change in quality is small (McFadden 1999).
Aggregation
The convention in aggregating welfare measures derived from discrete data over
individuals has been to multiply the average CV of the sample by the population size
(Bockstael, McConnell et al. 1991).  The same procedure can be carried out for
segments of the population based on location or income strata, for example.  Following
the potential Pareto improvement criterion, if the benefits net of costs are greater than
zero the gainers could compensate the losers thus implying that the change (potentially)
results in a net benefit.
Empirical Applications
Equation (4.17) has been used in a number of empirical applications in the areas of
environmental and transport economics to calculate the CV from discrete data.
It is important to point out that this formula has been used in environment and transport
economics to derive welfare measures not only from SPDCM data such as
(Adamowicz, Swait et al. 1997) which investigated the inclusion of and difference
between perceptions and objective data, but also from a number of other forms of
discrete data.  For example, discrete RP data (Trajtenberg 1989), referendum contingent
valuation data (Adamowicz, Boxall et al. 1999), combined RP and SP data
(Adamowicz, Louviere et al. 1994; Adamowicz, Swait et al. 1997; Louviere, Hensher et
2329
DERIVING WELFARE MEASURES FROM STATED PREFERENCE DISCRETE CHOICE MODELLING EXPERIMENTS
Deriving welfare measures from SPDCM experiments
CHERE Discussion Paper 48 – August 2002 24
al. 2000) and combined contingent valuation and SPDCM data (Adamowicz, Boxall et
al. 1999).
Despite its use in the environmental and transport economics fields, as will be discussed
in Section 5, this method has not been used explicitly with SPDCM data to elicit
welfare measures in the health economics arena to date.  However, it has been used with
RP data in the health economics field.  For example, this method has been used by
(Gertler 1987) to investigate the welfare implications of user fees in Peru, by (Feldman
1994) in an analysis of the change in consumer surplus from a merger of health plans,
and by (Puig-Junoy 1998) to derive the compensating variation for emergency visits,
while the probit form has been used by (Clarke 1998) in a travel cost approach applied
to mammographic screening.
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5.  REVIEW OF WELFARE MEASUREMENT FROM SPDCM DATA
IN THE HEALTH ECONOMICS LITERATURE
SPDCM has increasingly been used in the health economics field to model preferences
for health care related goods and services.  In doing so, a number of studies have used
the coefficients from the estimated IUFs to calculate measures of willingness to pay for
individual attributes and for entire goods and services.  This section provides an audit of
those studies which have calculated WTP from SPDCM data, briefly discusses the
methods used to derive WTP values from SPDCM data in the literature and compares
these to the theoretically correct method set out in Section 3.
A review of the health economics literature was undertaken.  The search strategy is
outlined in Appendix One.  The review found 10 studies had calculated the WTP for a
change in a single attribute, referred to in the literature as the “marginal WTP”, and 7
studies that had estimated the WTP for a an entire good or service from SDPCM or
conjoint analysis data.  These two groups are not mutually exclusive.
WTP for individual attributes
Recall that the IUF can be described as follows:
� �� �� � � � � � � � � � (5.1)
where �� �  is the vector of attributes, including price and quality, of the ��� good as
viewed by the ��� individual and  � �  is a vector of personal characteristics for individual
�.
Upon estimating the coefficients on the attributes, the � s, in equation (5.1), a number
of studies
15 have interpreted the marginal rate of substitution (MRS) between an
individual attribute and the price attribute as the marginal willingness to pay for a
change in a single attribute as follows:
15(Ryan and Huges 1997; Ryan 1999; Ryan 1999; Gyrd-Hansen 2000; Ryan 2000; Scott
2001)
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where � �  represents attribute 1, the attribute of interest, and � is price.  The numerator
is interpreted as the marginal utility of this attribute and the denominator is the marginal
disutility of price or cost.
This interpretation is appropriate if the alternative whose attribute has changed is
chosen with certainty.  However, which alternative will be chosen in a stated preference
discrete choice experiment is inherently uncertain.  Interpreting the ratio of the
coefficient on the attribute of interest to the price coefficient as the marginal welfare
effect is “not entirely consistent with the random utility model if the welfare effect
being examined is a change in one of several possible alternatives”, in which case the
probability of choosing that alternative must be taken into account (Adamowicz, Boxall
et al. 1999:467).  In contrast, the equation outlined in Section 3 for calculating the CV
(equation 4.17) implicitly weights the welfare change by the probability of choice and is
therefore consistent with random utility theory.  McFadden suggests that equation (5.2)
will approximate WTP for small quality improvements (McFadden 1999).
WTP for goods or services
A number of studies
16 have calculated the WTP arising from a change in all levels of a
good or service (which is implicitly the same as estimating the WTP for a new entire
new commodity) using the following formula:










where subscript �  represents the attributes describing the good or service in question
and subscript  � denotes price.  This method simply involves the summation of the
product of marginal willingness to pay described above in equation (5.2) and the change
in levels across all attributes.  As with the case of the marginal willingness to pay
formula, this formula is not consistent with random utility theory as it does not take
16(Ryan and Huges 1997; Johnson, Desvousges et al. 1998; Ryan 1999; Gyrd-Hansen
2000; Johnson, Mathews et al. 2000; Ryan 2000)
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account of the probability of choosing the good in question and is appropriate only if
that alternative is chosen with certainty.  If, however, the good or service is one of a
number of alternatives in the choice set, as is the case in SPDCM experiments, then the
probability of choosing that alternative should be taken into account.  As outlined in
Section 4, a change in a good or service with a low probability of being chosen will
have a small welfare impact while the converse case will have a large welfare impact
(Bockstael, McConnell et al. 1991).  For example, a change in the quality attributes of a
good in the choice set which has a very low probability of being chosen should result in
a low WTP since changing an attribute of a good which no one chooses will have little
effect on welfare.
An important issue is whether the method used in the health economics literature to date
to derive WTP values from SPDCM data (equation 5.3) is ever consistent with Small
and Rosen’s method (equation 4.17).  The answer is yes, but only under two very
specific assumptions.  First that there are only two choice options in the choice set and
second if an approximation is made.  To show the circumstances in which the two
equations are equivalent, equation 5.3 is first rewritten as:










Since � �  represents the difference in the levels of the attributes across the two
alternatives in the choice set, equation 5.4 can be simplified further to:




















For equation 5.6 to be equivalent to Small and Rosen’s formula (equation 4.17) two
requirements must be met.  First, the choice set must contain only two alternatives, that
is a binary choice, that is if the choice set contains 3 or more alternatives 5.6 is not
equivalent to 4.17, and second the following approximation must be imposed:
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� � �




� � �� � �
� � � (5.7)





















� � � � � �
� �
� �� � ��





� � �� � �
�
(5.9)
which is equivalent to equation (5.6) where  � � �  is interpreted as the marginal utility of
income � .  In general, however, the method used in the health economics literature to
date (equation 5.3) is not equivalent to the theoretically consistent method (equation
4.17).
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6.  EMPIRICAL APPLICATION:  DERIVING WELFARE MEASURES
FROM AN SPDCM EXPERIMENT
Having outlined the methods of deriving welfare measures from discrete data that are
consistent with microeconomic welfare theory, this section presents an empirical
application that aims to put that theory into practice.  In particular, a SPDCM
experiment is developed and estimated using data on patient preferences for preventive
asthma medication
17.  The coefficients from this estimated model were then used to
calculate the compensating variation.
Unlike many other survey instruments, a new SPDCM questionnaire is developed for
each new choice experiment.  There are five main steps involved in developing and
estimating an SPDCM experiment: determination of attributes and levels; experimental
design; questionnaire design; data collection; and analysis.  Each step is outlined below
with reference to the asthma SPDCM experiment.
1. Attributes and levels
The first stage in developing an SPDCM experiment is to identify a number of attributes
or characteristics that describe the decision at hand.  The attributes and levels associated
with the choice of asthma medication were identified from: the literature; discussions
with respiratory clinicians; and most importantly from structured interviews with
asthmatics.  The cost attributes were chosen to represent the spread of prices of
preventive asthma medication.  $0 is the lower bound and $100 is the upper bound.  $20
was selected to be close to the Pharmaceutical Benefits Schedule (PBS) co-payment
price of $21.90.  $80 was chosen to represent the cost of asthma medications not listed
on the PBS.  Allowing for a large spread in the cost levels is important in order to
ensure that the maximum WTP is elicited.  The asthma SPDCM experiment involved 10
attributes, 7 of which have 4 levels, the remaining 3 have 2 levels.  The attributes and
levels are contained at Table 1.
In health economics goods and services have typically been valued based on health
outcomes, for example, number of deaths prevented, reduction in blood pressure etc.
�� The asthma SPDCM study discussed here was a pilot study of a questionnaire that is part of a 3 period
cross over randomised controlled trial of three preventive asthma medications being conducted by the
Cooperative Research Centre for Asthma.
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SPDCM recognises that in addition to health outcomes, non health outcomes and
process attributes may also be important in decision making regarding health care (Ryan
1999).  As such, the attributes identified as important in the choice between preventive
asthma medications have been sorted into these three sub groups in Table 1.  The
measures of value derived from this SPDCM experiment will therefore include more
than health outcomes.
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Cost Total cost of the drug to you for





Repeats In order to pick up your
prescription and repeats for each
6 month period you will have to





Administration You take the drug via: � an aerosol inhaler
� a dry powder inhaler, e.g. Turbuhaler or
Accuahaler
� a tablet
� both an inhaler and a tablet
How often You need to take the drug: � once a day
� twice a day







On this drug you will
experience:
� minimal symptoms once a week or  less
� exercise breathlessness, cough or wheeze
once a week
� chest tightness doing normal activities
requiring reliever twice a week
� awaking at night with asthma requiring




Compared to most people in
your age group you are able to
participate in:
� all usual daily activities without the use
of a reliever
� all usual daily activities provided you use
a reliever for some of these activities
� most usual daily activities provided you
use your reliever most of the time
� a few usual daily activities provided you
use a reliever all the time
Sporting/strenuous
activities
You are able to participate in: � all the sporting or strenuous activity you
want without difficulty
� all the sporting or strenuous activity you
want with the use of reliever
� a restricted range of the sporting and
strenuous activity you want with the use
of a reliever
� no sporting or other strenuous activity
Side effects On this drug you will
experience:
� no side effects
� tremors, palpitations, nervousness or
headache
� oral thrush
� occasional hoarseness of speech
�������������������
Dr recommendation Your doctor says that this drug: � is the best for your asthma
� will give you satisfactory control of your
asthma
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2. Experimental design
The experimental design was developed by combining the levels of the attributes into
scenarios which respondents saw in the questionnaire
18.  Given the experiment involves
7 attributes with 4 levels and 3 attributes with 2 levels, the full factorial design consists
of 4
7 x 2
3 = 13,1072 scenarios, clearly too large to be completed by a single respondent.
To reduce the number of scenarios, an orthogonal fractional factorial design was
employed which contained 256 scenarios.  Two designs were originally combined in
this study.  The first design contained 12 scenarios using the extreme levels, that is the
first or last level on each attribute.  The second design contained 256 scenarios and was
broken into 16 random versions of 16 scenarios.  The rationale for combining two
designs is it allows all respondents to face an identical set of 12 scenarios which allow
for greater statistical precision when investigating the end points of the design (the
lowest and highest levels on each attribute) and also allows the respondent population to
be segmented into different groups.  The design consisting of 16 random versions of 16
scenarios allows investigation of the response surface.
A number of scenarios were altered in the design due to implausible combinations of
three attributes: the daily activities, symptoms and sporting activities.  These
combinations were randomly replaced with plausible combinations.  An example of an
implausible scenario was one that stated that on the hypothetical asthma medication the
individual would be able to participate in “all the sporting or strenuous activity you
want without difficulty”, and yet have the worst symptom level “waking at night with
asthma requiring the use of reliever more than 4 times a week” and the worst daily
activity level, namely that the individual is only able to participate in “a few usual daily
activities provided [they] use a reliever all the time”.  The resulting design was still
reasonably orthogonal and balanced in terms of the number of times each level of an
attribute was seen in a scenario.  Thus, a trade off was made between full orthogonality
and the plausibility of the scenarios since there is the possibility that respondents will
not take the questionnaire seriously if the scenarios are unrealistic.
18 The experimental design used in this pilot study was developed by Professor Jordan Louviere.
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3. Questionnaire Design
The third step involved the development of the questionnaire in which respondents were
presented with the hypothetical scenarios.  The design containing 12 scenarios was
combined with a single random version of 16 scenarios to produce a questionnaire
containing 28 scenarios.  The questionnaire consisted of a “report card” in which
respondents ranked their current asthma medication against the same attributes and
levels used in the design; demographic questions and 28 hypothetical scenarios.  Under
each scenario respondents were faced with 3 choices: the hypothetical asthma
medication outlined in the scenario; their current asthma medication as described in the
report card; or no asthma medication.  The third option, no asthma medication, was
included to ensure respondents were not forced to make a choice between two
alternatives, of which they may choose neither in practice.  An example of a scenario
and choice question are contained in Appendix 2.
4. Data Collection
The pilot study was conducted in Sydney, Australia, in August 2000 on a sample of 30
asthmatics obtained from an existing database.  Three interviewers were used in this
study, each with a sub sample of 10 respondents.  On completion of the questionnaire
all respondents were asked specific and open ended debriefing questions regarding the
questionnaire.  In particular, concerning: the ease of answering; the relevance of
attributes and appropriateness of levels; and how respondents chose between the 3
options they were presented with; and whether there were some attributes that were
more important than others in making this decision.
5. Model estimation
The choice between the three asthma medication options was modelled in a random
utility framework.  As outlined in Section 4, RUT proposes that utility, which is a latent
variable, can be separated into an explainable and a stochastic component as follows:
�� �� �� � � � � �     (6.1)
where �� � is the utility derived from choice  �  by individual �, �� �  is the explainable or
systematic component of utility and  �� � is the random component.  Assuming a linear
functional form, the systematic component of the IUF can be described as follows:
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� �� �� � � � � � � � � �     (6.2)
where �� �  is the vector of attributes of the  ��� asthma medication choice as viewed by
the ��� individual and  � �  is a vector of personal characteristics for individual �
(Maddala 1983).  Thus �  and �  are vectors of parameters which represent the
influence of the medication attributes and individual characteristics on the systematic
component of the IUF.  In this model the effect of each attribute,� , on the IUF is
assumed to be homogeneous across all respondents.
Respondents choose the alternative j to maximise their utility given the alternatives in
the choice set.  Individual choice behaviour is assumed to be probabilistic.  The
probability that a respondent will choose a given alternative is represented as:
� � � ��
� ���
� ���





� � � � � �







� �� �� �







where � � � is the probability individual � will choose asthma medication option 1 given
the choice set  � .
Assuming a Type 1 extreme value error distribution produces the conditional logit










� �     (6.4)
The logit specification implies a difference in utility model.  As such, the effect of the
individual characteristics, which by definition are the same for a given individual across
the j choice alternatives, will cancel out in the estimation process.  In order to include
the effect of individual characteristics, they must be interacted with a variable that does
vary, such as one of the attributes or a dummy variable created for the choice
alternatives, also referred to as alternative specific constants.  In this study individual
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characteristics such as income, age and gender were interacted with the alternative
specific constant.
Values of the two attributes in the design that can be interpreted as numerical or ordered
variables, cost and number of repeats, have been coded by centring them around their
mean.  For example, the mean of the levels on the cost attribute ($0, $20, $80, $100) is
$50 which was then subtracted from each of the levels to give -$50, -$30, $30 and $50.
As such, the impact of the mean enters the constant.  The remaining eight attributes are
qualitative and do not have a clear ordering.  These variables have been effects coded.
An example of effects coding for a four level attribute is contained in Table 2.
Parameters are estimated for the first 3 effects coded levels while the parameter on the
last level of each attribute is obtained by taking the negative sum of the estimated
parameters on the first 3 levels.  An advantage of effects coding rather than dummy
coding is that the former does not confound the effect of the attributes with the
alternative specific constant while the latter does.  Effects coding orthogonalises the
effect of the attributes to the constant (Adamowicz, Louviere et al. 1994).
��������������������������������������������������
������ ��� ��� ���
0 1 0 0
1 0 1 0
2 0 0 1
3 -1 -1 -1
Results
The SP responses to the choice of one of the 3 asthma medication alternatives:
hypothetical medication; current medication; or no medication, were analysed using a
multinomial logit model.  As with all conditional logit models, one of the sets of
parameters must be normalised to equal zero and used as the reference to which the
estimates for the other two alternatives are compared.  In this case the coefficients for
the “no medication” option were set to zero which implies that the utility of choosing
the no medication option is also set at zero
19.
19 Choice of the no medication alternative as the reference was based on the fact that the database
consisted of information on the levels of the attributes of the hypothetical scenarios and the respondents
current medication (collected via the report card) but did not contain information regarding the levels of
the attributes associated with not taking an asthma medication, so less information was lost.
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The results indicated that the majority of respondents chose to remain on their current
asthma medication and that the probability of choosing the “no medication” option was
very small, 0.0093 or less than one percent.  Given the very low number of times the
“no medication” option was chosen (21 out of 360 observations) and due to the small
numbers used in this pilot study (n=30), use of the no medication option as the reference
would result in statistical imprecision of the estimated parameters.  As a result, this
choice option was dropped from the data set as were those 3 respondents who chose this
alternative
20.  This left 27 respondents with 324 observations.  The model was then
estimated in STATA as a binary conditional logit model where the relevant choice was
between the hypothetical medication and the respondent’s current medication.  The




Constant -3.820 0.738 0.000*
Cost -0.015 0.002 0.000*
Repeat -0.033 0.082 0.684
Adminfx1 -0.610 0.365 0.095***
Adminfx2 -0.139 0.506 0.783
Adminfx3 0.780 0.771 0.312
Oftenfx1 0.326 0.207 0.116
Sympfx1 1.100 0.374 0.003*
Sympfx2 0.758 0.414 0.067***
Sympfx3 -1.588 0.569 0.005*
Activfx1 0.169 0.260 0.516
Activfx2 0.024 0.408 0.952
Sportfx1 0.808 0.363 0.026**
Sportfx2 1.674 0.566 0.003*
Sportfx3 -1.645 0.553 0.003*
Monitfx1 0.024 0.181 0.896
Sidefx1 0.792 0.467 0.090***
Sidefx2 -1.030 0.641 0.108










(a) * significant at 1% level, ** significant at 5% level, *** significant at 10% level
(b) LR test for null hypothesis that all coefficients except the intercept are jointly zero; critical value at 1% level is
approximately 36.1908.
20 Eliminating choice options due to the low number of respondents who chose that option has been
undertaken elsewhere.  See, for example, (Louviere, Hensher et al. 2000) in which case one of the four
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The model provided a good fit to the data with a pseudo R
2 of 0.4912.  The likelihood
ratio test for the null hypothesis that all coefficients except the intercept are jointly zero
is rejected at the 1% critical level, implying that the model has good explanatory power.
The coefficients on each attribute indicate the impact of that attribute on the probability
of choosing the hypothetical asthma alternative.  For example, cost has a negative
impact on the decision to choose the hypothetical asthma medication.  This is in accord
with the property of the IUF outlined in Section 4.  All effects were in the expected
direction.  The effect of 6 levels of attributes were statistically significant at the 1
percent level, 1 at the 5 percent level and 3 at the 10 percent level.  The alternative
specific constant is included to indicate a general preference for either the hypothetical
scenario or for the respondents’ current asthma medication.  A preference for the former
would be represented by a positive coefficient while a preference for the latter would be
indicated by a negative coefficient.  Given the ASC in the above model is negative this
indicates that respondents have a general preference for their current asthma
medication.
Welfare Calculations
The parameter estimates from the random utility model estimated above are employed
to calculate the welfare measures associated with changes in the described asthma
medication.  The process is as follows: the parameters estimated above, the  � � , are
used in conjunction with the attribute levels, the  ��,  to calculate numerical values for
the conditional IUFs.  The values of the IUFs,  � � , are then used in equation (4.17) to
indirectly calculate the compensating variation.
Using this process, moving from the worst to the best hypothetical asthma medication
results in a CV of $34.72 per prescription.  This figure was calculated by changing all
attributes of the hypothetical drug from the worst to best levels.  This implies that if the
quality of all the characteristics of the hypothetical drug were to improve, the
respondent would have to have $34.72 taken away from them to leave them at the same
utility level as they were prior to the quality improvement.  That is, the respondent
would be willing to pay $34.72 to secure the improved asthma medication.
high speed rail choices was dropped from the analysis of travel choice because that alternative was only
chosen by 2 people.
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These results are preliminary and drawn from SP data collected from a small sample
and as such, should be interpreted as demonstrating the method of deriving welfare
measures from SPDCM data that are consistent with microeconomic welfare theory
rather than as a definitive result.
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7.  CONCLUSION AND AREAS FOR FUTURE RESEARCH
An essential component of policy evaluation in the health sector is the measurement of
changes in welfare arising from new policies or modifications to existing policy.
SPDCM offers one source of data from which to value changes in welfare.  The discrete
choice model used in SPDCM focuses on a comparison of the alternatives in the choice
set and their underlying characteristics.   SPDCM is therefore well suited to estimating
changes in welfare from problems characterised by substitution among alternatives as is
often the case in the health sector.  SPDCM can be used as an alternative to RP data or
more importantly can be used in cases where RP data is lacking.
This paper has investigated the use of SPDCM data as a source of information from
which to indirectly derive measures of welfare that are consistent with microeconomic
welfare theory.  To do this, an overview of SPDCM was first provided, including its
uses, underlying theory, methods and application.   The theory of exact welfare
measurement was reviewed in the familiar case of continuous data followed by a
discussion of how these methods have been modified in order to be used with SPDCM
data, that is, to take account of discrete data within a random utility context.
A review of the health economics literature highlighted that the methods used to derive
estimates of WTP from SPDCM to date differ from the theoretically correct method
suggested by Small and Rosen.  A key difference is that the few studies that have
estimated WTP figures from SPDCM data in the health economics field use a method
that does not take account of the probability of choosing each alternative in the choice
set.  As such, a change in the levels of the attributes could potentially reduce the
probability that the good or service in question will be chosen as respondents have the
opportunity to substitute to more attractive alternatives in the choice set.  The method
used in the literature to date is appropriate, however, when the chosen alternative is
known with certainty.  Alternatively, it can be used as an approximation to the change
in welfare if the change in the quality of the attributes is very small.
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The feasibility of the theoretically consistent method proposed by Small and Rosen was
demonstrated in an application to elicit the CV for asthma medication.  This represents
the first application of this method using SPDCM data in the health sector.  The results
of this application are purely preliminary.  Due to the small sample, no attempt should
be made to generalise the results from this sample to the population of asthmatics.  The
results should be interpreted as demonstrating the method of deriving welfare measures
from SPDCM data that are consistent with microeconomic welfare theory rather than as
a definitive result.
There are a number of key questions which need to be addressed in future research
before the method set out in this paper can be considered a standard tool.  An important
area for future research is around the validity of welfare measures calculated from SP
data.  In particular, how does what people say they would do compare to the actual
decisions they make in the market place.  This in turn relates to the validity of the
SPDCM method in general.  An important part of future research must be to test the
assumption underlying SPDCM that the choices people make in hypothetical scenarios
reflect their preferences.  The general question of the validity and reliability of SPDCM
experiments has been addressed elsewhere (Louviere, Hensher et al. 2000; Louviere
1988), however further investigation will be required in the health economics field with
a particular focus on welfare measures estimated from this technique.  One method of
validation is to compare welfare measures derived from RP data with those derived
from SPDCM data using the same group of individuals.
An appropriate extension of this research is to include income in the empirical
application rather than approximating this with the negative of the price coefficient.
Using each individual’s income also allows for a separate WTP calculation per person
which can be aggregated to produce a mean WTP over the study population to produce
an overall welfare gain.  Future work will allow marginal utility of income to vary
which is likely to be more consistent with economic theory.
An important extension of this work is to calculate the WTP for a product or program
using both the method currently used in the literature and the theoretically consistent
method outlined in this paper in order to ascertain the implications of using the former
rather than the latter.
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Other areas for future research include: explicitly incorporating uncertainty into the
attributes in the SPDCM experiment in order to derive welfare measures under
uncertainty; investigating the use of non linear functional forms in the estimation of the
conditional logit model and their impact on the resulting welfare measures; comparing
welfare measures derived from SPDCM data with those derived via the contingent
valuation method; and investigating whether preferences elicited from SPDCM methods
satisfy the axioms of completeness, reflexivity, transitivity, convexity and
monotonicity.
Once a number of the issues outlined above have been addressed, particularly the issue
of validity, the method presented here to derive welfare measures from SPDCM data
could potentially move from being theoretically plausible to become a practical tool in
the health economics field and potentially fill the gap left by the relative lack of RP data
in the health sector.
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All articles published in languages other than English were excluded as were articles
published before 1980.  Duplicates were excluded when more than one database was
employed simultaneously.
��������������
First, a search of the literature was carried out on three databases concurrently –
Medline, Premedline, Econlit and Embase.  The search terms “discrete choice”, “choice
modeling”, “choice modelling”, “conjoint analysis” were used in conjunction with
“health” – this yielded 86 citations eligible for inclusion.
The second stage of the search was to determine the number of articles within the above
set that that also contained the key words or subject headings “willingness to pay”,
“welfare”, “compensating variation”, or “equivalent variation”. To do this, these key
words were combined with the above results. A total of 26 of the 86 original citations
contained the relevant key words.  On obtaining the articles they were screened to
ascertain their relevance from which the number of relevant studies was further reduced
to 15.  The literature review was supplemented by a review of references from
bibliographies of relevant papers.
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APPENDIX TWO
����������������������������������������������������������������������
Total cost of the drug to you for a 3 month
supply is:
Free
In order to pick up your prescription and
repeats for each 6 month period you will
have to go to the chemist:
Twice
You take the drug via: a tablet
You need to take the drug: Once a day
On this drug you will experience: Exercise breathlessness, cough or wheeze
once a week
Your doctor says that this drug: is the best for your asthma
Compared to most people in your age
group you are able to participate in:
all usual daily activities without the use of
a reliever
You are able to participate in: all the sporting or strenuous activity you
want without difficulty
You measure your morning peak flow: Never




�� Your current preventer medication
�� The preventer medication in the situation above
�� No preventer medication
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